Created in 2010 (Switzerland), RIPRAZO HCT own 2951 sister brands and 17477 competing brands. The RIPRAZO HCT brand is owned by NOVARTIS N, a company listed in Zurich. The ISIN, the company's International Securities Identification Number, is CH0012005267. The sector of RIPRAZO HCT is Drug Manufacturers.